HPV Vaccine Market
Nov 08, 2024
Preventing Cervical Cancer Through Screening And HPV Vaccines
Cervical cancer stands as the fourth most diagnosed cancer among women globally, trailing breast, colorectal, and lung cancers. However, its impact is disproportionately heavy on developing nations, where prevalence rates soar. In 2022, WHO estimated approximately 660,000 new cases of cervical cancer and 350,000 de...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
